Nuvation Bio Inc. (NYSE: NUVB), a late clinical-stage, global biopharmaceutical company tackling some of the greatest unmet needs in oncology, today a ...

Vanda pharmeucitals received a rejection for its drug tradipitant, causing the company management to criticize the FDA.

Patient and public health groups worry about a potential patent grant to Gilead Sciences for the HIV drug lenacapavir in ...

Yavapai County will be part of the High Intensity Drug Trafficking Area program, which opens up federal resources to police ...

Developing advanced drug screening tools is crucial for the advancement of personalized medicine and the creation of more ...

The FDA has approved Zevra Therapeutics' Miplyffa (arimoclomol) as the first treatment for neurological symptoms of ...

A D.C. drugmaker has been dealt a major setback in its long-running bid to bring its treatment for a chronic gastrointestinal ...

On World Alzheimer’s Day, we examine how a timely diagnosis can prepare someone with early dementia, and the pros and cons of ...

The market for weight-loss treatments is expected to see 16 new drugs vying for a slice of the lucrative business currently ...

Discover how advances from various biotechs are bridging treatment gaps in menopause care, offering hope for managing ...

Following an investigational new drug application clearance from the FDA, a phase 1 trial plans to evaluate CD-001.

The Food and Drug Administration (FDA) has cleared an investigational new drug application for the novel treatment, APTN-101, ...